FDA Commissioner calls for collaborative approach to health regulation

Globalisation and how it affects the quality of medicines and medical devices was the key issue addressed at the Medicines and Healthcare Products Regulatory Agency’s 9th Annual Lecture at the Royal College of Physicians in London.

Dr Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA), spoke about the growing threat of counterfeit medicines and medical devices and the challenges that international regulators such as the FDA and the MHRA face in ensuring that people continue to have access to high quality medicines and medical devices.

Commissioner Hamburg’s lecture can be viewed or read in text format via the MHRA website.

Over 243 stakeholders from a range of different health and science organisations attended the event and a panel including the agency’s Chief Executive Dr Ian Hudson and Commissioner Hamburg answered questions from the audience.